Recent Vascular Clinical Trials

Learn more about recent vascular clinical trials:

ENGAGE PAS: U.S. Endurant Stent Graft System Post Approval Study
Medtronic Vascular, Inc.

CREATE PAS: Carotid Revascularization with ev3 Arterial Technology Evolution Post Approval Study
ev3, Clinical Protocol P-2611

MarrowStim™ PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects with Severe Peripheral Arterial Disease (PAD)
Biomet Biologics, IDE Number BB-IDE 13996

A Multicenter, Open Label, Prospective, Non-Randomized Study Of The INCRAFT™ Stent Graft System In Subjects With Abdominal Aortic Aneurysms
Cordis Corporation, P11-4601

LEVANT 2: A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Moxy™ Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal Arteries
Lutonix, CL0002-04

SYMPLICITY HTN-3: Renal Denervation in Patients with Uncontrolled Hypertension
Medtronic, Inc., IP125 1B

ROADSTER Study: Investigation of Flow Altered, Short Transcervical Carotid Artery Stenting in Patients with Significant Carotid Artery Disease
Silk Road Medical, SRM-2012-02

EUCLID (Examining the Use of tiCagreLor In paD) Study
AstraZeneca , DC5135C00001

BEST-CLI (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia)
National Institutes of Health, U01HL107407

CREST-2 (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial)
National Institutes of Health